PMID: 16639884Apr 28, 2006Paper

Human-toxicological effect and damage factors of carcinogenic and noncarcinogenic chemicals for life cycle impact assessment

Integrated Environmental Assessment and Management
Mark A J HuijbregtsDik van de Meent

Abstract

Chemical fate, effect, and damage should be accounted for in the analysis of human health impacts by toxic chemicals in life-cycle assessment (LCA). The goal of this article is to present a new method to derive human damage and effect factors of toxic pollutants, starting from a lognormal dose-response function. Human damage factors are expressed as disability-adjusted life years (DALYs). Human effect factors contain a disease-specific and a substance-specific component. The disease-specific component depends on the probability of disease occurrence and the distribution of sensitivities in the human population. The substance-specific component, equal to the inverse of the ED50, represents the toxic potency of a substance. The new method has been applied to calculate combined human damage and effect factors for 1,192 substances. The total range of 7 to 9 orders of magnitude between the substances is dominated by the range in toxic potencies. For the combined factors, the typical uncertainty, represented by the square root of the ratio of the 97.5th and 2.5th percentile, is a factor of 25 for carcinogenic effects and a factor of 125 for noncarcinogenic effects. The interspecies conversion factor, the (non)cancer effect conversion...Continue Reading

References

Jun 1, 1995·Regulatory Toxicology and Pharmacology : RTP·F C Lu
Aug 1, 1995·Regulatory Toxicology and Pharmacology : RTP·J SeedJ A Foran
Aug 1, 1993·Risk Analysis : an Official Publication of the Society for Risk Analysis·D KrewskiM Szyszkowicz
Jul 1, 1997·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·M VadmalM Arlen
Jun 10, 1998·Regulatory Toxicology and Pharmacology : RTP·A G Renwick, N R Lazarus
Jul 22, 1998·Regulatory Toxicology and Pharmacology : RTP·M N PietersW Slob
Feb 11, 1999·Risk Analysis : an Official Publication of the Society for Risk Analysis·W Slob, M N Pieters
Oct 16, 1999·Critical Reviews in Toxicology·T VermeireB C Hakkert
Mar 15, 2000·Regulatory Toxicology and Pharmacology : RTP·C F WilkinsonR Reiss
Aug 15, 2001·Regulatory Toxicology and Pharmacology : RTP·J J ChenR L Kodell
Jul 24, 2002·Clinics in Laboratory Medicine·M Desmond Burke
Nov 22, 2002·Risk Analysis : an Official Publication of the Society for Risk Analysis·Pierre CrettazOlivier Jolliet
Nov 22, 2002·Risk Analysis : an Official Publication of the Society for Risk Analysis·David PenningtonOlivier Jolliet
Nov 22, 2002·Risk Analysis : an Official Publication of the Society for Risk Analysis·Patrick Hofstetter, James K Hammitt
Dec 14, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Aug 25, 2005·Environmental Toxicology and Chemistry·Dik van de Meent, Mark A J Huijbregts
Dec 1, 1997·Environmental Toxicology and Pharmacology·D Hattis

❮ Previous
Next ❯

Citations

Sep 5, 2013·Journal of Environmental Management·Carolina AlfonsínMa Teresa Moreira
Jun 15, 2011·Chemistry Central Journal·Mihai V Putz
Nov 19, 2011·Environmental Health Perspectives·Jennifer M LogueBrett C Singer
Sep 29, 2011·International Journal of Molecular Sciences·Mihai V PutzVasile Ostafe
Jun 5, 2015·The Science of the Total Environment·Yumi KobayashiStuart J Khan
Nov 17, 2009·Journal of Hazardous Materials·Sérgio Alberto Morais, Cristina Delerue-Matos
Mar 14, 2007·Environment International·Ralph K RosenbaumOlivier Jolliet
Sep 4, 2012·Environment International·Peter FantkeOlivier Jolliet
Jul 15, 2015·PloS One·Michael MayoMark A Chappell
Sep 25, 2016·Risk Analysis : an Official Publication of the Society for Risk Analysis·Wouter FransmanDerk H Brouwer
Mar 13, 2016·Risk Analysis : an Official Publication of the Society for Risk Analysis·Vincent Nedellec, Ari Rabl
Dec 13, 2018·Environmental Health Perspectives·Peter FantkeThomas E McKone
Feb 9, 2020·International Journal of Environmental Research and Public Health·Xiaobo Xue Romeiko
Jul 8, 2020·The International Journal of Life Cycle Assessment·Lei HuangJane Bare
Feb 6, 2019·Environmental Science and Pollution Research International·Anubha GoelAnitha V Veetil
Oct 20, 2020·Risk Analysis : an Official Publication of the Society for Risk Analysis·Olivier JollietPeter Fantke
Jan 6, 2021·The Science of the Total Environment·Yasmine EmaraMatthias Finkbeiner
Oct 17, 2020·Environmental Research·D A SarigiannisA Gotti
Dec 5, 2009·Environmental Science & Technology·Jaap StruijsMark A J Huijbregts
Aug 11, 2021·Environmental Science & Technology·Yuanliang JinDeyi Hou
Mar 23, 2018·Environmental Science & Technology·Montserrat NúñezStephan Pfister
Feb 3, 2012·Environmental Science & Technology·Matthew J EckelmanMenachem Elimelech
Sep 13, 2011·Environmental Science & Technology·Peter FantkeOlivier Jolliet
Nov 19, 2014·Environmental Science & Technology·Abhishek Chaudhary, Stefanie Hellweg
Oct 8, 2015·Environmental Science & Technology·Ralph K RosenbaumThomas E McKone
Oct 16, 2014·Environmental Science & Technology·Mohamad SleimanHugo Destaillats

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.